Phase
Condition
Amenorrhea
Polycystic Ovarian Syndrome
Reproductive Health
Treatment
Biochemical, hormonal and metabolic phenotyping
Cardiovascular autonomic function studies
24-hour Ambulatory blood pressure monitoring
Clinical Study ID
Ages 18-40 Female Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria
Group I
Body mass index between 18.5 and 25.0 kg/m2.
Group 1 ovulatory dysfunction [World Health Organization (WHO) classification].
Normal/low gonadotrophin levels [follicle-stimulating hormone (FSH) and luteinizing (LH) < 10 IU/l] and low estradiol (< 50 pg/ml).
Moderate-vigorous intensity physical activity (> 5 hours per week) plus low energy availability (< 30 kcal/per kg of lean mass).
Exclusion of secondary etiologies
Informed consent signed.
Group II:
Polycystic ovary syndrome phenotype I, II and III [National Institute of Health (NIH)-2012] with hyperandrogenemia (http://prevention.nih.gov/workshops/2012/resources.aspx).
Body mass index between 18.5 and 40.0 kg/m2.
Informed consent signed.
Group III:
Polycystic ovary syndrome phenotype IV (NIH-2012) (http://prevention.nih.gov/workshops/2012/resources.aspx).
Body mass index between 18.5 and 40.0 kg/m2.
Informed consent signed.
Group IV:
Body mass index between 18.5 and 25.0 kg/m2.
Regular menses.
Normal gonadotropins and estradiol levels at follicular phase.
Moderate-vigorous intensity physical activity (> 5 hours per week) with normal energy availability (> 30 kcal/per kg of lean mass).
Informed consent signed.
Group V:
No signs or symptoms of hyperandrogenism.
No exercise or mild intensity physical activity.
Regular menses.
Body mass index between 18.5 and 40.0 kg/m2.
Informed consent signed.
Exclusion Criteria (Groups I-V)
Oral drugs interfering with ovulation (glucocorticoids, antipsychotics, antidepressants, contraceptives, sex steroids and/or opioids) for the previous 6 months to study inclusion.
Current pregnancy or lactation, or during the previous 6 months to study inclusion.
Asherman's syndrome or outflow tract disorders.
Current smoking or alcohol intake > 40 g per day.
Previous diagnosis of glucose intolerance, hypertension, dyslipidemia, known heart or lung diseases, kidney disease, liver disease, celiac disease or any other malabsorptive condition, chronic inflammatory disease or malignancy.
Study Design
Connect with a study center
Endocrinology and Nutrition
Madrid, 28034
SpainActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.